Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Kraft, Andrew
One or more keywords matched the following items that are connected to
Kraft, Andrew
Item Type
Name
Academic Article
The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells.
Academic Article
A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomas.
Academic Article
The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim.
Academic Article
Phosphorylation of AML1/RUNX1 regulates its degradation and nuclear matrix association.
Academic Article
Bortezomib in combination with celecoxib in patients with advanced solid tumors: a phase I trial.
Academic Article
Proteasome inhibitor PS-341 (VELCADE) induces stabilization of the TRAIL receptor DR5 mRNA through the 3'-untranslated region.
Academic Article
Combination therapy of recurrent prostate cancer with the proteasome inhibitor bortezomib plus hormone blockade.
Concept
Bortezomib
Search Criteria
Bortezomib